by Co-Diagnostics | Feb 28, 2018 | News Release
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that ongoing research and... by Co-Diagnostics | Feb 21, 2018 | News Release
Shipment includes 10,000 tests to be sold as Research Use Only by Joint Venture SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular... 